L2L L2L Microarray Analysis Tool

Results for C03D.profile.d50

Results summary View all lists in L2L MDB View all genes in C03D.profile.d50
List Name Description Total
probes
Expected
matches
Actual
matches
Fold
Enrichment
Binomial
p-value
17aag_ovca_dn Down-regulated 24 hours following treatment of human ovarian cancer cells (A2780) with the HSP90 inhibitor 17AAG (60 nM) 129 0.32 4 12.54 3.21e-04
dac_cgi_fibro_dn Downregulated by DAC treatment in LD419 fibroblast cells, with 5' CpG island 12 0.03 2 67.42 3.97e-04
adip_diff_cluster5 Strongly upregulated at 24 hours during differentiation of 3T3-L1 fibroblasts into adipocytes (cluster 5) 67 0.17 3 18.11 6.43e-04
oxstress_breastca_dn Downregulated by H2O2, Menadione and t-BH in breast cancer cells 16 0.04 2 50.57 7.17e-04
et743_sarcoma_24hrs_dn Down-regulated at 24 hours following treatment with Et-743 in at least 8 of 11 sarcoma cell lines 163 0.40 4 9.93 7.74e-04
dac_fibro_dn Downregulated by DAC treatment in LD419 fibroblast cells 17 0.04 2 47.59 8.11e-04
tsadac_hypometh_hyperac_ovca_up Genes with basally hypomethylated promoters upregulated by the combination of TSA and DAC in ovarian carcinoma (CP70) cells, with hyperacetylated promoters upon activation 17 0.04 2 47.59 8.11e-04
5azac_hepg2_dn Down-regulated in human hepatoma cells (HepG2) following 48 hrs treatment with 2.5 microM 5-aza-2-deoxycytidine (5azaC). 1830 4.52 13 2.87 8.28e-04
stemcell_neural_up Enriched in mouse neural stem cells, compared to differentiated brain and bone marrow cells 2805 6.93 17 2.45 8.51e-04
middleage_dn Downregulated in fibroblasts from middle-age individuals, compared to young 23 0.06 2 35.18 1.49e-03
p21_p53_early_dn Down-regulated at early timepoints (4-8 hrs) following ectopic expression of p21 (CDKN1A) in OvCa cells, p53-dependent 23 0.06 2 35.18 1.49e-03
serum_fibroblast_cellcycle Cell-cycle dependent genes regulated following exposure to serum in a variety of human fibroblast cell lines 197 0.49 4 8.21 1.56e-03
uvb_scc_up Upregulated by UV-B light in squamous cell carcinoma cells 198 0.49 4 8.17 1.58e-03
stemcell_embryonic_up Enriched in mouse embryonic stem cells, compared to differentiated brain and bone marrow cells 1989 4.92 13 2.64 1.72e-03
o6bg_resist_medulloblastoma_dn Up-regulated in a medulloblastoma cell line resistant to both BCNU and O6-BG, compared to sensitive parent line (D-341 MED) 109 0.27 3 11.13 2.61e-03
wnt3a_mammary_up Up-regulated in normal mouse mammary gland cells following treatment with Wnt3A (top 124 genes). 133 0.33 3 9.12 4.56e-03
et743_sarcoma_dn Down-regulated following treatment with Et-743 at any timepoint in at least 8 of 11 sarcoma cell lines 459 1.13 5 4.41 6.09e-03
5azac-tsa_hepg2_dn Down-regulated in human hepatoma cells (HepG2) following 24 hrs treatment with 2.5 microM 5-aza-2-deoxycytidine (5azaC) and 24 hrs treatment with both 5azaC and 500 nM trichostatin A (TSA). 2343 5.79 13 2.24 6.65e-03
p21_any_dn Down-regulated at any timepoint (4-24 hrs) follwing ectopic expression of p21 (CDKN1A) in OvCa cells 50 0.12 2 16.18 6.92e-03
et743_sarcoma_48hrs_dn Down-regulated at48 hours following treatment with Et-743 in at least 8 of 11 sarcoma cell lines 304 0.75 4 5.32 7.25e-03
uvc_high_d9_dn Progressively down-regulated through 24 hrs following treatment of WS1 human skin fibroblasts with UVC at a high dose (50 J/m^2) (cluster d9) 53 0.13 2 15.27 7.74e-03
rcc_nl_up Upregulated in VHL-rescued renal carcinoma vs. normal renal cells (Fig. 2d+e) 899 2.22 7 3.15 7.77e-03
uvc_xpcs_8hr_dn Down-regulated at 8 hours following treatment of XPB/CS fibroblasts with 3 J/m^2 UVC 911 2.25 7 3.11 8.32e-03
hippocampus_development_prenatal Highly expressed in prenatal mouse hippocampus (cluster 1) 58 0.14 2 13.95 9.21e-03
cmv_hcmv_timecourse_20hrs_up Up-regulated in fibroblasts following infection with human cytomegalovirus (at least 3-fold, with Affymetrix change call, in at least two consectutive timepoints), with maximum change at 20 hours 174 0.43 3 6.97 9.52e-03

Raw data (tab-delimited .txt)